Early detection of lung cancer recurrence after stereotactic ablative radiation therapy: radiomics system design

Salma Dammak; David Palma; Sarah Mattonen; Suresh Senan; Aaron D. Ward

doi:10.1117/12.2292444

27 February 2018 Early detection of lung cancer recurrence after stereotactic ablative radiation therapy: radiomics system design

Salma Dammak, David Palma, Sarah Mattonen, Suresh Senan, Aaron D. Ward

Author Affiliations +

Proceedings Volume 10575, Medical Imaging 2018: Computer-Aided Diagnosis; 1057503 (2018) https://doi.org/10.1117/12.2292444
Event: SPIE Medical Imaging, 2018, Houston, Texas, United States

Abstract

Stereotactic ablative radiotherapy (SABR) is the standard treatment recommendation for Stage I non-small cell lung cancer (NSCLC) patients who are inoperable or who refuse surgery. This option is well tolerated by even unfit patients and has a low recurrence risk post-treatment. However, SABR induces changes in the lung parenchyma that can appear similar to those of recurrence, and the difference between the two at an early follow-up time point is not easily distinguishable for an expert physician. We hypothesized that a radiomics signature derived from standard-of-care computed tomography (CT) imaging can detect cancer recurrence within six months of SABR treatment. This study reports on the design phase of our work, with external validation planned in future work. In this study, we performed cross-validation experiments with four feature selection approaches and seven classifiers on an 81-patient data set. We extracted 104 radiomics features from the consolidative and the peri-consolidative regions on the follow-up CT scans. The best results were achieved using the sum of estimated Mahalanobis distances (Maha) for supervised forward feature selection and a trainable automatic radial basis support vector classifier (RBSVC). This system produced an area under the receiver operating characteristic curve (AUC) of 0.84, an error rate of 16.4%, a false negative rate of 12.7%, and a false positive rate of 20.0% for leaveone patient out cross-validation. This suggests that once validated on an external data set, radiomics could reliably detect post-SABR recurrence and form the basis of a tool assisting physicians in making salvage treatment decisions.

Citation Download Citation

Salma Dammak, David Palma, Sarah Mattonen, Suresh Senan, and Aaron D. Ward "Early detection of lung cancer recurrence after stereotactic ablative radiation therapy: radiomics system design", Proc. SPIE 10575, Medical Imaging 2018: Computer-Aided Diagnosis, 1057503 (27 February 2018); https://doi.org/10.1117/12.2292444

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available